Exhibit 107
Calculation of Filing Fee Table
Form S-3
(Form Type)
Tyra Biosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration | |||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | 457(c) | 15,373,253(1) | $17.45(2) | $268,186,398.59(2) | 0.0001476 | $39,584.31 | ||||||||
| Total Offering Amounts | $268,186,398.59 | $39,584.31 | ||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||
| Total Fee Offsets | — | |||||||||||||||
| Net Fee Due | $39,584.31 | |||||||||||||||
| (1) | Consists of (i) 9,286,023 shares of the registrant’s common stock issued to the selling securityholders and (ii) 6,087,230 shares of the registrant’s common stock issuable to certain of the selling securityholders upon the exercise of outstanding pre-funded warrants. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the registrant is also registering an indeterminate number of additional shares of common stock issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction. |
| (2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) of the Securities Act, and based upon the average of the high and low prices for a share of the registrant’s common stock as reported on the Nasdaq Global Select Market on March 15, 2024 (such date being within five business days of the date that this registration statement was filed with the U.S. Securities and Exchange Commission). |